Strides buys soft gel capsule facility in U.S.

Capsules
Strides says a new soft gel facility it has bought in the U.S. will give it much more capacity and compliments its other facilities. (Pixabay)

Strides Pharma has picked up a soft gel manufacturing facility in the U.S. from Micelle BioPharma for very little but intends to invest in it. 

The Indian drugmaker said today that it bought the Riviera Beach, Florida facility for $500,000 but will invest another $10 million to add other capabilities. It said it is one of the very few manufacturing plants in the U.S. with a soft gel capsule suite for formulations with containment. It also said it has the only  FDA  approved integrated manufacturing‐packaging SGC facility in the U.S.

RELATED: FDA investigators discover key Strides Pharma quality records in shredding room

Strides, which now has eight formulation facility globally, the facility has passed several U.S. inspections.

Upcoming Webinar

Lifecycle Management Strategies Targeted For Patient Populations with Swallowing Disorders

Hear from industry experts as they discuss life cycle management strategies for patients with swallowing disorders and the overall impact on patient perception. The webinar will include several panel speakers representing different perspectives and case study examples. Save your spot and register today!

That is not true of all of Strides' other facilities. The FDA last month issued a warning letter to one of Strides' facilities in India. The agency said the drug testing records at a Strides Pharma plant in a shredding room, indicating the facilities had been data integrity issues, as well as other problems. 

Suggested Articles

AbbVie has seen blossoming market share for immunology launches Rinvoq and Skyrizi—and it's eyeing Allergan's neurology biz for a boost, too.

While Novo's Rybelsus launch has slowed due to the pandemic, another version of the med, Ozempic posted strong sales.

Lonza is on deck to help manufacture AstraZeneca's COVID-fighting antibody duo at its Portsmouth, New Hampshire site.